<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="case-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">BMC Med Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">BMC Med. Genet</journal-id>
<journal-title-group>
<journal-title>BMC Medical Genetics</journal-title>
</journal-title-group>
<issn pub-type="epub">1471-2350</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30606125</article-id>
<article-id pub-id-type="pmc">6318863</article-id>
<article-id pub-id-type="publisher-id">738</article-id>
<article-id pub-id-type="doi">10.1186/s12881-018-0738-y</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Molecular characterization of two novel intronic variants of <italic>NIPBL</italic> gene detected in unrelated Cornelia de Lange syndrome patients</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Krawczynska</surname>
<given-names>Natalia</given-names>
</name>
<address>
<email>nataliakrawczynska@gumed.edu.pl</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wierzba</surname>
<given-names>Jolanta</given-names>
</name>
<address>
<email>kwierz@gumed.edu.pl</email>
</address>
<xref ref-type="aff" rid="Aff3">3</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jasiecki</surname>
<given-names>Jacek</given-names>
</name>
<address>
<email>jjasiecki@gumed.edu.pl</email>
</address>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3634-7562</contrib-id>
<name>
<surname>Wasag</surname>
<given-names>Bartosz</given-names>
</name>
<address>
<phone>(48) 58 349 15 32</phone>
<email>bwasag@gumed.edu.pl</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0531 3426</institution-id><institution-id institution-id-type="GRID">grid.11451.30</institution-id><institution>Department of Biology and Medical Genetics, </institution><institution>Medical University of Gdansk, </institution></institution-wrap>1 Debinki Street, 80-211, Gdansk, Poland </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.467122.4</institution-id><institution>Laboratory of Clinical Genetics, </institution><institution>University Clinical Centre, </institution></institution-wrap>Gdansk, Poland </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0531 3426</institution-id><institution-id institution-id-type="GRID">grid.11451.30</institution-id><institution>Department of Pediatrics, Hematology and Oncology, </institution><institution>Medical University of Gdansk, </institution></institution-wrap>Gdansk, Poland </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0531 3426</institution-id><institution-id institution-id-type="GRID">grid.11451.30</institution-id><institution>Department of General Nursery, </institution><institution>Medical University of Gdansk, </institution></institution-wrap>Gdansk, Poland </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0531 3426</institution-id><institution-id institution-id-type="GRID">grid.11451.30</institution-id><institution>Department of Pharmaceutical Microbiology, </institution><institution>Medical University of Gdansk, </institution></institution-wrap>Gdansk, Poland </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>3</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>3</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>20</volume>
<elocation-id>1</elocation-id>
<history>
<date date-type="received">
<day>13</day>
<month>3</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>21</day>
<month>12</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2019</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p id="Par1">Cornelia de Lange syndrome (CdLS), a rare, multisystemic disorder, has been linked to genetic alterations in <italic>NIPBL</italic>, <italic>SMC1A</italic>, <italic>SMC3</italic>, <italic>HDAC8,</italic> and <italic>RAD21</italic> genes. Approximately 60% of CdLS patients harbor various <italic>NIPBL</italic> variants. Genetic changes predicted to affect <italic>NIPBL</italic> gene splicing represent 15% of all <italic>NIPBL</italic> genetic abnormalities. Yet, only a few studies have investigated the molecular consequences of such variants.</p>
</sec>
<sec>
<title>Case presentation</title>
<p id="Par2">This study reports two novel, intronic <italic>NIPBL</italic> genetic variants in unrelated CdLS patients with the characteristic phenotype. A c.6954 + 3A &gt; C substitution and a c.5862 + 1delG deletion were identified, one of each, in a 6 year-old boy and 39 month-old girl. Further studies confirmed that both variants introduce premature termination codons, resulting in the formation of truncated proteins p.(Ser2255LeufsTer20) and p.(Leu1955Ter), respectively.</p>
</sec>
<sec>
<title>Conclusion</title>
<p id="Par3">Single nucleotide alterations located within the conserved splice-donor site of intronic regions of the <italic>NIPBL</italic> gene can give rise to a premature termination of the translation and cause significant changes in the sequence of mRNA transcripts and NIPBL protein structure and function. The latter underline development of Cornelia de Lange syndrome phenotype.</p>
</sec>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (10.1186/s12881-018-0738-y) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>CdLS</kwd>
<kwd>Cornelia de Lange syndrome</kwd>
<kwd>NIPBL gene</kwd>
<kwd>Splice-site variants</kwd>
<kwd>Next generation sequencing</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution>Narodowe Centrum Nauki (PL)</institution>
</funding-source>
<award-id>UMO-2014/15/B/NZ5/03503</award-id>
<principal-award-recipient>
<name>
<surname>Wasag</surname>
<given-names>Bartosz</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p id="Par17">Cornelia de Lange Syndrome (CdLS; OMIM# 1227470, 300,590, 610,759, 614,701, and 300,882) is a rare, multisystemic disorder characterized by the facial dysmorphism, limb malformations, intellectual disability, and developmental delay [<xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR6">6</xref>]. Hirsutism, growth failure, gastrointestinal problems, and behavioral abnormalities are commonly observed. Less frequent symptoms include congenital heart defects, hearing loss, seizures, and dysfunctional behaviors such as self-injury and rejection of social interactions. Projected incidence of CdLS is 1 per 10- to 30-thousand live births, although this may be a miscalculation due to an underdiagnosis of CdLS with mild clinical presentation [<xref ref-type="bibr" rid="CR6">6</xref>].</p>
<p id="Par18">Genetic alterations of <italic>NIPBL</italic>, <italic>SMC1A</italic>, <italic>SMC3</italic>, <italic>HDAC8</italic>, and <italic>RAD21</italic> genes are believed to trigger the development of Cornelia de Lange syndrome. Approximately 60% of CdLS patients harbor genetic variants in the <italic>NIPBL</italic> gene, which encodes human delangin, a homolog of Drosophila <italic>Nipped-B</italic> and fungal <italic>Scc2</italic> protein of the cohesin complex [<xref ref-type="bibr" rid="CR7">7</xref>]. The majority of pathogenic <italic>NIPBL</italic>variants are distinctively unique in individual patients. Genetic mutations affecting <italic>SMC1A</italic>, <italic>SMC3</italic>, <italic>HDAC8,</italic> and <italic>RAD21</italic> genes account for 10% of CdLS cases [<xref ref-type="bibr" rid="CR8">8</xref>–<xref ref-type="bibr" rid="CR11">11</xref>]. Pathogenic variants within these genes affect the cohesion complex involved in sister chromatid cohesion and transcriptional gene regulation [<xref ref-type="bibr" rid="CR8">8</xref>–<xref ref-type="bibr" rid="CR13">13</xref>]. However, in 30% of CdLS patients, no molecular alterations have been identified.</p>
<p id="Par19">The <italic>NIPBL</italic> gene, located on the short arm of chromosome 5 at p13.2, is 189 kbp in length and contains 47 exons that can be alternatively spliced into three isoforms of 2804, 2697, and 1101 amino acids. The 2804 amino acid nuclear protein plays a role in the maintenance of proper chromatin structure and in the communication between promoters and transcriptional enhancers [<xref ref-type="bibr" rid="CR7">7</xref>]. The genetic alterations predicted to affect <italic>NIPBL</italic> splicing represent about 15% of all known variants in the <italic>NIPBL</italic> gene [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. Nevertheless, the alterations functional consequences on the mRNA splicing process are often not characterized.</p>
<p id="Par20">This study presents two novel intronic <italic>NIPBL</italic> variants and reveals their impact on <italic>NIPBL</italic> mRNA transcripts.</p>
</sec>
<sec id="Sec2">
<title>Case presentation</title>
<p id="Par21">Two unrelated patients (hereinafter referred to as Individual 1 and Individual 2), who met the clinical criteria for a classic subtype of Cornelia de Lange syndrome, were enrolled in the study [<xref ref-type="bibr" rid="CR1">1</xref>]. Both cases were diagnosed at the Department of Pediatrics, Hematology and Oncology, Medical University of Gdansk. The study was approved by the institutional review board (NKEBN/395/2014; NKEBN/395–504/2014; NKEBN/395–288/2014). Written informed consent to participate in the study was obtained from the patients’ parents.</p>
<p id="Par22">Detailed clinical data are presented in Table <xref ref-type="table" rid="Tab1">1</xref>. Individual 1 was a 6 year-old boy. He was born at 35 weeks of gestation. His birth length was 50 cm, weight 2100 g, and occipital frontal circumference 29 cm. Distinctive CdLS facial features have been presented, although no congenital malformations such as limb defects were seen. Presently, he exhibits self-injurious behavior, an attention deficit, and a learning disability.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Clinical features of CdLS patients enrolled to the study</p></caption><table frame="hsides" rules="groups"><thead><tr><th></th><th></th><th>Individual 1 CdLS24</th><th>Individual 2 CdLS62</th></tr></thead><tbody><tr><td rowspan="2"></td><td>Age</td><td>6 years</td><td>3 months</td></tr><tr><td>Gender</td><td>Male</td><td>Female</td></tr><tr><td>System</td><td>Specific feature</td><td></td><td></td></tr><tr><td rowspan="9">Facial dysmorphy</td><td>Synophrys</td><td>+</td><td>+</td></tr><tr><td>Long eyelashes</td><td>+</td><td>+</td></tr><tr><td>Short nose</td><td>+</td><td>+</td></tr><tr><td>Anteverted nostrils</td><td>+</td><td>+</td></tr><tr><td>Long philtrum</td><td>+</td><td>+</td></tr><tr><td>Broad or depressed nasal bridge</td><td>+</td><td>+</td></tr><tr><td>Thin lips with downturned corners</td><td>+</td><td>+</td></tr><tr><td>Cleft palate</td><td>+</td><td>+</td></tr><tr><td>Low set ears</td><td>+</td><td>+</td></tr><tr><td rowspan="4">Growth</td><td>Birth weight (pregnancy week)</td><td>2100 g (35 hbd)</td><td>1640 g (39 hbd)</td></tr><tr><td>Birth length</td><td>50 cm</td><td>44 cm</td></tr><tr><td>Birth head circumference</td><td>29 cm</td><td>27,5 cm</td></tr><tr><td>Postnatal microsomy</td><td>+</td><td>+</td></tr><tr><td rowspan="2">Development</td><td>Developmental delays or intellectual disability</td><td>+</td><td>Ne</td></tr><tr><td>Learning disability</td><td>+</td><td>Ne</td></tr><tr><td rowspan="4">Behavior</td><td>Attention deficit disorder</td><td>+</td><td>Ne</td></tr><tr><td>Hyperactivity</td><td>+</td><td>Ne</td></tr><tr><td>Self-injurious behavior</td><td>+</td><td>Ne</td></tr><tr><td>Autistic-like features</td><td>–</td><td>Ne</td></tr><tr><td rowspan="4">Musculoskeletal</td><td>Absent arms or forearms</td><td>–</td><td>Right hand ectrodactyly</td></tr><tr><td>5th finger clinodactyly</td><td>+</td><td>+</td></tr><tr><td>Abnormal palmar crease</td><td>+</td><td>+</td></tr><tr><td>Short 1st knuckle/proximally placed thumb</td><td>+</td><td>+</td></tr><tr><td>Cardiac</td><td>Type of malformation</td><td>Ventricular septal defect</td><td>Tetralogy of Fallot</td></tr><tr><td rowspan="2">Gastrointestinal</td><td>Poor feeding</td><td>+</td><td>+</td></tr><tr><td>Gastroesophageal reflux</td><td>+</td><td>+</td></tr><tr><td rowspan="2">Skin</td><td>Hirsutism</td><td>+</td><td>+</td></tr><tr><td>Cutis marmorata</td><td>+</td><td>+</td></tr><tr><td rowspan="4">Neurologic</td><td>Seizures</td><td>–</td><td>–</td></tr><tr><td>Hypertony</td><td>+</td><td>+</td></tr><tr><td>Deafness or hearing loss</td><td>+</td><td>+</td></tr><tr><td>Central nervous system malformation</td><td>–</td><td>Dandy Walker malformation</td></tr><tr><td>Uro genital</td><td>Cryptorchidism</td><td>+</td><td>–</td></tr></tbody></table><table-wrap-foot><p>+ feature present, − feature not present, Ne feature not evaluated</p></table-wrap-foot></table-wrap></p>
<p id="Par23">Individual 2 was a 3 month-old girl. She was born at 39 weeks of gestation. Her birth length was 44 cm, weight 1640 g, and occipital frontal circumference 27.5 cm. In addition to the distinctive CdLS facial features, she had a Dandy Walker malformation, tetralogy of Fallot, and right hand ectrodactyly. Moreover, feeding difficulties and gastroesophageal reflux were diagnosed.</p>
<p id="Par24">Genomic DNA was extracted from peripheral blood samples using the Genomic DNA From Blood Kit (Macherey-Nagel) as per the manufacturer’s protocol. The quantity and quality of isolated DNA was determined with NanoDrop ND-1000 and Qubit Fluoremeter (Thermo Fisher Scientific).</p>
<p id="Par25">Mutational analysis was performed using NimbleGen Seqcap EZ HyperCap (Roche Diagnostics) and MiSeq (Illumina). Probes were designed to enrich exons and 25 bp of flanking introns. The entire coding sequences of the following genes have been tested: <italic>NIPBL</italic>, <italic>SMC1A</italic>, <italic>SMC3</italic>, <italic>RAD21</italic>, <italic>HDAC8</italic>, <italic>STAG1</italic>, <italic>SGOL1</italic>, <italic>PDS5A</italic>, <italic>PTTG1</italic>, <italic>TAF6</italic>, <italic>ESCO2</italic>, <italic>WAPAL</italic>, <italic>CDCA5</italic>, <italic>KMT2A</italic>, <italic>DDX11</italic>,<italic>ESPL1</italic>, <italic>PDS5B</italic>, <italic>PLK1</italic>, <italic>AURKB</italic>, <italic>ESCO1</italic>, <italic>MAU2</italic>, <italic>ATRX</italic>, <italic>STAG2</italic>, and <italic>RECQL4</italic>. The read length was pair-end and a cut-off of 30% for the Variant Allele Frequency was applied. The analysis was performed using IGV (Broad Institute) and Alamut (Interactive Biosoftware) software. The nomenclature of the alterations was based on <italic>NIPBL</italic> mRNA sequence NM_133433.3, in accordance with the recommendations of the Human Genome Variation Society (<ext-link ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">http://varnomen.hgvs.org/</ext-link>) [<xref ref-type="bibr" rid="CR15">15</xref>]. Variants’ pathogenicity was classified based on the American College of Medical Genetics (ACMG) guidelines [<xref ref-type="bibr" rid="CR16">16</xref>]. The presence of <italic>NIPBL</italic> alterations was confirmed by an independent PCR followed by bidirectional Sanger sequencing. For Individual 1, exon-intron boundaries were amplified using NIPBL_F_40 (5′-TGTGTGTTTATCCTTTGCTTGC-3′) and NIPBL_R_40 (5′-GGACTAAGACTCCACCCTGTTG-3′) primes. Exon 32 of <italic>NIPBL</italic> gene of Individual 2 was amplified with NIPBL_F_32 (5′-GGCTAAAGCATAACAAAAGTATATT-3′) and NIPBL_R_32 (5′-AATAAATTTTCCCTACCAAAAGAA-3′) primers. PCR products were sequenced using a BigDye Terminator v3.1 Cycle Sequencing Kit and 3500 Series Genetic Analyzer (Thermo Fisher Scientific). Electropherograms were analyzed with Sequencer v.10 DNA Software (Gene Codes). Finally, both parents were genotyped in order to confirm de novo status of detected <italic>NIPBL</italic> variants.</p>
<p id="Par26">Total RNA was extracted from blood samples using the Tempus Spin RNA Isolation Reagent Kit (Thermo Fisher Scientific). iScript cDNA Synthesis Kit (Bio-Rad) was applied for cDNA synthesis. For Individual 1, exons 38–42 of the <italic>NIPBL</italic> gene were amplified with cF38 (5′-AAGCTATCATTGGTCTAGGATTT-3′) and cR42 (5′-AGTCACGTCTGTTTTTGCTG-3′) primers. Exons 30–35 of the <italic>NIPBL</italic> gene of Individual 2 were amplified using cF30 (5′-ATGAAGAGGGCATTAAGAAATT-3′) and cR35 (5′-GAAATCATTTTGCGTACTAC-3′) primers. PCR products were excised from agarose gel, purified with the Gel Extraction KIT (Macherey-Nagel), and cloned into pGEM-T Easy Vector Systems (Promega). Plasmids were isolated using Plasmid Mini (A&amp;A Biotechnology) and bidirectionally was sequenced with universal primers for pGEM-T Easy Vector.</p>
<p id="Par27">Mutational analysis of two CdLS patients performed by NGS revealed the presence of novel, heterozygous, intronic variants in the NIPBL gene. In Individual 1, a c.6954 + 3A &gt; C substitution was detected, while in Individual 2, a c.5862 + 1delG deletion was found. Molecular analysis performed on individuals’ parents confirmed de novo status of both alterations. Additional molecular studies performed with cDNA confirmed that both variants altered the splicing process. In Individual 1, intronic variant c.6954 + 3A &gt; C caused r.6764_6954del on the mRNA level. In Individual 2, c.5862 + 1delG deletion resulted in r.5862_5863ins5862 + 2_5862 + 41 insertion on the mRNA level. In both cases, according to protein alignment, the protein was shortened (see Additional file <xref ref-type="media" rid="MOESM1">1</xref>). In Individual 1, the protein consisted of 2274 aa (amino acids) and the last 20 aa were changed - p.(Ser2255LeufsTer20). In Individual 2, a termination codon was introduced at codson 1955 - p.(Leu1955Ter). In both patients, highly conserved HEAT domains were disrupted. The results of the mutational analysis and predicted proteins are presented at Fig. <xref ref-type="fig" rid="Fig1">1</xref>.<fig id="Fig1"><label>Fig. 1</label><caption><p>Variant analysis of both individuals. <bold>a-c</bold> Analysis of Individual 1 variant - c.6954 + 3A &gt; C. <bold>a</bold> Sequence analysis of exon 40 and intron 40 of the <italic>NIPBL</italic> gene. The wild-type control (top panel) and Individual 1 (bottom panel). The mutation is marked with a circle. <bold>b</bold> Sequence analysis of cDNA <italic>NIPBL</italic> gene. The wild-type control (top panel) and the bottom panel exhibit an in-frame deletion of exon 40 of <italic>NIPBL</italic> gene in Individual 1. <bold>c</bold> NIPBL protein alignment of the wild-type control (top panel) and the bottom panel of Individual 1 exhibit protein truncation and loss of H5 domain. <bold>d-f</bold> Analysis of Individual 2 variant - c.5862 + 1delG. <bold>d</bold> Sequence analysis of exon 32 and intron 32 of the <italic>NIPBL</italic> gene. The wild-type control (top panel) and Individual 2 (bottom panel). The mutation is marked with a circle. <bold>e</bold> Sequence analysis of cDNA <italic>NIPBL</italic> gene. The wild-type control (top panel) and the bottom panel exhibit an in-frame insertion of 40 nucleotides of intron 32 of <italic>NIPBL</italic> gene in Individual 2. <bold>f</bold> NIPBL protein alignment of the wild-type control (top panel) and he bottom panel of Individual 2 exhibit protein truncation and loss of H3, H4, and H5 domains</p></caption><graphic id="MO1" xlink:href="12881_2018_738_Fig1_HTML"></graphic></fig></p>
</sec>
<sec id="Sec3">
<title>Discussion and conclusion</title>
<p id="Par28">In this study, two novel, pathogenic variants affecting the conserved splice-donor site in the intronic regions of the <italic>NIPBL</italic> gene have been reported. Both alterations resulted in aberrant pre-mRNA splicing and caused the alteration of highly conserved HEAT domains. In Individual 1, the change of 20 aa (2255–2274) containing 13 aa of H4 domain and complete deletion of H5 domain has been identified. In Individual 2, deletion c.5862 + 1delG resulted in partial loss of the H3 domain (from 1954 aa) and complete deletion of H4 and H5 domains. As a result, the NIPBL ability to interact with other proteins could be severely damaged in both CdLS patients.</p>
<p id="Par29">There are five HEAT repeats, H1-H5, located within the C-terminal part of the NIPBL protein. These domains, particularly H2 and H3, play a significant role in the interaction with histone deacetylases 1 and 3 (HDAC1 and HDAC3) and may initiate chromatin-remodeling processes [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. In general, HEAT repeats have been found in various chromosome-associated proteins, which probably play a role in chromosome dynamics [<xref ref-type="bibr" rid="CR19">19</xref>].</p>
<p id="Par30">Genetic alterations such as frame shift mutations, affecting both RNA transcripts and proteins have been identified in CdLS patients with severe phenotypes. In contrast, point mutations, not affecting the reading frame, were generally seen in patients with mild phenotype [<xref ref-type="bibr" rid="CR6">6</xref>]. Individual 1, presented in this study, showed signs and symptoms seen in a severe CdLS phenotype, although no significant musculoskeletal abnormalities existed. This individual carried a c.6954 + 3A &gt; C substitution in intron 40 of the <italic>NIPBL</italic> gene. Molecular alterations located within exons 35–47 of the <italic>NIPBL</italic> gene have been linked to a mild CdLS phenotype by a previously published investigation [<xref ref-type="bibr" rid="CR6">6</xref>]. Individual 2 showed a spectrum of signs and symptoms seen in very severe phenotypes, including microsomy, severe limb and cardiac abnormalities, postnatal retardation, and prominent CdLS facial appearance. The more severe CdLS phenotype in Individual 2 can be explained by molecular findings. A c.5862 + 1delG deletion carried by Individual 2 resulted in an expression of a more dysfunctional NIPBL protein than in Individual 1.</p>
<p id="Par31">Individual 2 suffers from tetralogy of Fallot (ToF). In general, this type of cardiac abnormality is rarely seen in CdLS patients (approximately 1%) [<xref ref-type="bibr" rid="CR20">20</xref>]. One study reported three patients with ToF in a group of 310 CdLS individuals [<xref ref-type="bibr" rid="CR21">21</xref>]. In another study, based on an Asian population, only one individual with ToF was observed among 50 patients [<xref ref-type="bibr" rid="CR22">22</xref>]. EUROCAT studies identified two patients with ToF among 106 CdLS clinical cases [<xref ref-type="bibr" rid="CR23">23</xref>]. In general, tetralogy of Fallot was diagnosed in CdLS patients with severe phenotypes carrying different <italic>NIPBL</italic> variants including substitutions, in-frame deletions, or truncating variants. However, due to the limited number of CdLS patients with ToF, it is impossible to correlate this clinical feature with molecular data. Nevertheless, a girl with a severe, classical type of Cornelia de Lange syndrome was diagnosed with Fallot’s tetralogy and a large deletion encompassing exons 41–42 of the <italic>NIPBL</italic> gene (deletion expanding from intron 40 to part of intron 42 - c.6955–1095 _7263 + 3344del5227) [<xref ref-type="bibr" rid="CR24">24</xref>]. Also, the case of an 11 month-old CdLS girl with ToF and double lumen aortic arch has been reported; however, the molecular status of her <italic>NIPBL</italic> was unknown [<xref ref-type="bibr" rid="CR25">25</xref>]. In the current study, in Individual 2 (with ToF), an insertion of 40 bp of intron 32 of NIPBL transcript was identified. Other types of cardiovascular disorders are not a major criteria for CdLS, although occur fairly often [<xref ref-type="bibr" rid="CR20">20</xref>–<xref ref-type="bibr" rid="CR26">26</xref>].</p>
<p id="Par32">Congenital brain defects can be observed in CdLS patients, however they seem to be extremely rare. Individual 2 was diagnosed with the Dandy Walker malformation, a rare malformation that involves the cerebellum and fourth ventricle [<xref ref-type="bibr" rid="CR27">27</xref>]. The Dandy Walker malformation has not been reported in CdLS patients.</p>
<p id="Par33">It is accepted that genetic variants located at the exon-intron junctions of genes affect the splicing process, changing the sequence and structure of the protein and impairing its function. Therefore, such intronic variants can be definitely classified as pathogenic and responsible for the severe phenotypes of the patients [<xref ref-type="bibr" rid="CR18">18</xref>]. In the current study, we have presented two CdLS patients with novel, intronic <italic>NIPBL</italic> variants affecting both transcription and translation. These results underline the necessity for a comprehensive molecular analysis of intronic variants both on the DNA and RNA levels. Such studies can not only give new insights into the molecular mechanism of the disease, but may also allow us to perform a more detailed genotype-phenotype correlation in a group of CdLS patients.</p>
<p id="Par34">In summary, we have described two unrelated patients with Cornelia de Lange syndrome caused by de novo splice-site mutations in the <italic>NIPBL</italic> gene. In both individuals, the detected variants lead to a production of aberrant mRNA transcripts encoding truncated NIPBL proteins. In Individual 1 (c.6954 + 3A &gt; C; r.6764_6954del), the protein was shortened by 423 aa, with the last 20 aa changed. In Individual 2 (c.5862 + 1delG; r.5862_5863ins5862 + 2_5862 + 41), deletion of 743 aa was observed. These findings highlight that single nucleotide alterations located within the conserved splice-donor site of the intronic regions of the <italic>NIPBL</italic> gene could have a severe impact on the sequence and structure of both mRNA transcripts and proteins. Given this, a comprehensive molecular analysis of such genetic variants should be considered.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Additional file</title>
<sec id="Sec4">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="12881_2018_738_MOESM1_ESM.pdf"><label>Additional file 1:</label><caption><p>NIPBL protein alignment of both cases. NIPBL wt – first row – NIPBL alignment of wild type protein. NIPBL p1 – second row - NIPBL alignment of Individual 1 with c.6954 + 3A &gt; C variant. NIPBL p2 – third row - NIPBL alignment of Individual 2 with c.5862 + 1delG variant. (PDF 154 kb)</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>aa</term>
<def>
<p id="Par4">Amino acids</p>
</def>
</def-item>
<def-item>
<term>CdLS</term>
<def>
<p id="Par5">Cornelia de Lange syndrome</p>
</def>
</def-item>
<def-item>
<term>DNA</term>
<def>
<p id="Par6">Deoxyribonucleic acid</p>
</def>
</def-item>
<def-item>
<term>hbd</term>
<def>
<p id="Par7">Pregnancy week</p>
</def>
</def-item>
<def-item>
<term>HEAT</term>
<def>
<p id="Par8">Huntington, Elongation factor 3, the PR65/A subunit of PP2A and the lipid kinase Tor</p>
</def>
</def-item>
<def-item>
<term>IGV</term>
<def>
<p id="Par9">Integrative Genomics Viewer</p>
</def>
</def-item>
<def-item>
<term>mRNA</term>
<def>
<p id="Par10">messenger ribonucleic acid</p>
</def>
</def-item>
<def-item>
<term>ng</term>
<def>
<p id="Par11">Nanogram</p>
</def>
</def-item>
<def-item>
<term>NGS</term>
<def>
<p id="Par12">Next generation sequencing</p>
</def>
</def-item>
<def-item>
<term>NIPBL</term>
<def>
<p id="Par13">Nipped-B-like protein</p>
</def>
</def-item>
<def-item>
<term>pb</term>
<def>
<p id="Par14">Pars of bases</p>
</def>
</def-item>
<def-item>
<term>RNA</term>
<def>
<p id="Par15">Ribonucleic acid</p>
</def>
</def-item>
<def-item>
<term>ToF</term>
<def>
<p id="Par16">Tetralogy of Fallot</p>
</def>
</def-item>
</def-list>
</glossary>
<ack>
<p>We would like to thank the patients and their families for participating in this study.</p>
<sec id="FPar1">
<title>Funding</title>
<p id="Par35">This study was funded by grant from the National Science Centre Poland, project no. UMO-2014/15/B/NZ5/03503.</p>
</sec>
<sec id="FPar2">
<title>Availability of data and materials</title>
<p id="Par36">All relevant data are available as supplemental files to the manuscript. Raw data of next generation sequencing, detailed protocols, and analyzed data during this study are available from the corresponding author on reasonable request.</p>
</sec>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>Classification the patients in the study: JW. Conceived and designed the experiments: NK, BW. Performed the experiments: NK, JJ. Analyzed the data: NK, JJ, BW. Manuscript preparation: NK, JJ, BW, JW. All authors read and approved the final manuscript.</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar3">
<title>Ethics approval and consent to participate</title>
<p>The study was approved by the Ethical Committee of the Medical University of Gdansk, Poland (NKEBN/395/2014; NKEBN/395–504/2014; NKEBN/395–288/2014). Written informed consent to participate in the study and for publication of medical information and phenotype description was obtained from patients’ parents.</p>
</sec>
<sec id="FPar4">
<title>Consent for publication</title>
<p>Written informed consent for publication was obtained from patients’ parents.</p>
</sec>
<sec id="FPar5">
<title>Competing interests</title>
<p>The authors declare that they have no competing interest.</p>
</sec>
<sec id="FPar6">
<title>Publisher’s Note</title>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<mixed-citation publication-type="other">Kline AD, Krantz ID, Sommer A, Kliewer M, Jackson LG, FitzPatrick DR, Levin AV, Selicorni A. Cornelia de Lange syndrome: clinical review, diagnostic and scoring systems, and anticipatory guidance. Am J Med Genet A. 2007. 10.1002/ajmg.a.31757.</mixed-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<mixed-citation publication-type="other">Kawauchi S, Calof AL, Santos R, Lopez-Burks ME, Young CM, Hoang MP, Chua A, Lao T, Lechner MS, Daniel JA, Nussenzweig A, Kitzes L, Yokomori K, Hallgrimsson B, Lander AD. Multiple organ system defects and transcriptional dysregulation in the Nipbl+/− mouse, a model of Cornelia de Lange syndrome. PLoS Genet. 2009. 10.1371/journal.pgen.1000650.</mixed-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<mixed-citation publication-type="other">Dorsett D, Krantz ID. On the molecular etiology of Cornelia de Lange syndrome. Ann N Y Acad Sci. 2009. 10.1111/j.1749-6632.2008.03450.x.</mixed-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<mixed-citation publication-type="other">Boyle MI, Jespersgaard C, Brøndum-Nielsen K, Bisgaard AM, Tümer Z. Cornelia de Lange syndrome. Clin Genet. 2015. 10.1111/cge.12499.</mixed-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<mixed-citation publication-type="other">Kuzniacka A, Wierzba J, Ratajska M, Lipska BS, Koczkowska M, Malinowska M, Limon J. Spectrum of <italic>NIPBL</italic> gene mutations in polish patients with Cornelia de Lange syndrome. J Appl Genet. 2013. 10.1007/s13353-012-0126-9.</mixed-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<mixed-citation publication-type="other">Mannini L, Cucco F, Quarantotti V, Krantz ID, Musio A. Mutation Spectrum and genotype–phenotype correlation in Cornelia de Lange syndrome. Hum Mutat. 2013. 10.1002/humu.22430.</mixed-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<mixed-citation publication-type="other">Nizon M, Henry M, Michot C, Baumann C, Bazin A, Bessières B, Blesson S, Cordier-Alex MP, David A, Delahaye-Duriez A, Delezoïde AL, Dieux-Coeslier A, Doco-Fenzy M, Faivre L, Goldenberg A, Layet V, Loget P, Marlin S, Martinovic J, Odent S, Pasquier L, Plessis G, Prieur F, Putoux A, Rio M, Testard H, Bonnefont JP, Cormier-Daire V. A series of 38 novel germline and somatic mutations of <italic>NIPBL</italic> in Cornelia de Lange syndrome. Clin Genet. 2016. 10.1111/cge.12720.</mixed-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<mixed-citation publication-type="other">Krantz ID, McCallum J, DeScipio C, Kaur M, Gillis LA, Yaeger D, Jukofsky L, Wasserman N, Bottani A, Morris CA, Nowaczyk MJ, Toriello H, Bamshad MJ, Caewy JC, Rappaport E, Kawauchi S, Lander AD, Calof AL, Li HH, Devoto M, Jackson LG. Cornelia de Lange syndrome is caused by mutations in NIPBL, the human homolog of Drosophila melanogaster nipped-B. Nat Genet. 2004. 10.1038/ng1364.</mixed-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<mixed-citation publication-type="other">Musio A, Selicorni A, Focarelli ML, Gervasini C, Milani D, Russo S, Vezzoni P, Larizza L. X-linked Cornelia de Lange syndrome owing to <italic>SMC1L1</italic> mutations. Nat Genet. 2006. 10.1038/ng1779.</mixed-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<mixed-citation publication-type="other">Deardorff MA, Kaur M, Yaeger D, Rampuria A, Korolev S, Pie J, Gil-Rodríguez C, Arnedo M, Loeys B, Kline AD, Wilson M, Lillquist K, Siu V, Ramos FJ, Musio A, Jackson LS, Dorsett D, Krantz ID. Mutations in cohesin complex members SMC3 and SMC1A cause a mild variant of Cornelia de Lange syndrome with predominant mental retardation. Am J Hum Genet. 2007. 10.1086/511888.</mixed-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<mixed-citation publication-type="other">Deardorff MA, Wilde JJ, Albrecht M, Dickinson E, Tennstedt S, Braunholz D, Mönnich M, Yan Y, Xu W, Gil-Rodríguez MC, Clark D, Hakonarson H, Halbach S, Michelis LD, Rampuria A, Rossier E, Spranger S, Van Maldergem L, Lynch SA, Gillessen-Kaesbach G, Lüdecke HJ, Ramsay RG, McKay MJ, Krantz ID, Xu H, Horsfield JA, Kaiser FJ. <italic>RAD21</italic> mutations cause a human cohesinopathy. Am J Hum Genet. 2012. 10.1016/j.ajhg.2012.04.019.</mixed-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<mixed-citation publication-type="other">Deardorff MA, Bando M, Nakato R, Watrin E, Itoh T, Minamino M, Saitoh K, Komata M, Katou Y, Clark D, Cole KE, De Baere E, Decroos C, Di Donato N, Ernst S, Francey LJ, Gyftodimou Y, Hirashima K, Hullings M, Ishikawa Y, Jaulin C, Kaur M, Kiyono T, Lombardi PM, Magnaghi-Jaulin L, Mortier GR, Nozaki N, Petersen MB, Seimiya H, Siu VM, Suzuki Y, Takagaki K, Wilde JJ, Willems PJ, Prigent C, Gillessen-Kaesbach G, Christianson DW, Kaiser FJ, Jackson LG, Hirota T, Krantz ID, Shirahige K. <italic>HDAC8</italic> mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle. Nature. 2012. 10.1038/nature11316.</mixed-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<mixed-citation publication-type="other">Yuan B, Pehlivan D, Karaca E, Patel N, Charng WL, Gambin T, Gonzaga-Jauregui C, Sutton VR, Yesil G, Bozdogan ST, Tos T, Koparir A, Koparir E, Beck CR, Gu S, Aslan H, Yuregir OO, Al Rubeaan K, Alnaqeb D, Alshammari MJ, Bayram Y, Atik MM, Aydin H, Geckinli BB, Seven M, Ulucan H, Fenercioglu E, Ozen M, Jhangiani S, Muzny DM, Boerwinkle E, Tuysuz B, Alkuraya FS, Gibbs RA, Lupski JR. Global transcriptional disturbances underlie Cornelia de Lange syndrome and related phenotypes. J Clin Invest. 2015. 10.1172/JCI77435.</mixed-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<mixed-citation publication-type="other">Teresa-Rodrigo ME, Eckhold J, Puisac B, Pozojevic J, Parenti I, Baquero-Montoya C, Gil-Rodríguez MC, Braunholz D, Dalski A, Hernández-Marcos M, Ayerza A, Bernal ML, Ramos FJ, Wieczorek D, Gillessen-Kaesbach G, Pié J, Kaiser FJ. Identification and functional characterization of two Intronic <italic>NIPBL</italic> mutations in two patients with Cornelia de Lange syndrome. Biomed Res Int. 2016. 10.1155/2016/8742939.</mixed-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<mixed-citation publication-type="other">den Dunnen JT, Dalgleish R, Maglott DR, Hart RK, Greenblatt MS, McGowan-Jordan J, Roux AF, Smith T, Antonarakis SE, Taschner PEM. HGVS recommendations for the description of sequence variants: 2016 update. Hum Mutat. 2016. 10.1002/humu.22981.</mixed-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<mixed-citation publication-type="other">Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015. 10.1038/gim.2015.30.</mixed-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<mixed-citation publication-type="other">Teresa-Rodrigo ME, Eckhold J, Puisac B, Dalski A, Gil-Rodríguez MC, Braunholz D, Baquero C, Hernández-Marcos M, de Karam JC, Ciero M, Santos-Simarro F, Lapunzina P, Wierzba J, Casale CH, Ramos FJ, Gillessen-Kaesbach G, Kaiser FJ, Pié J. Functional characterization of <italic>NIPBL</italic> physiological splice variants and eight splicing mutations in patients with Cornelia de Lange syndrome. Int J Mol Sci. 2014. 10.3390/ijms150610350.</mixed-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<mixed-citation publication-type="other">Jahnke P, Xu W, Wülling M, Albrecht M, Gabriel H, Gillessen-Kaesbach G, Kaiser FJ. The Cohesin loading factor NIPBL recruits histone deacetylases to mediate local chromatin modifications. Nucleic Acids Res. 2008. 10.1093/nar/gkn688.</mixed-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<mixed-citation publication-type="other">Neuwald AF, Hirano T. HEAT repeats associated with Condensins, Cohesins, and other complexes involved in chromosome-related functions. Genome Res. 2000. 10.1101/gr.147400.</mixed-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<mixed-citation publication-type="other">Chatfield KC, Schrier SA, Li J, Clark D, Kaur M, Kline AD, Deardorff MA, Jackson LS, Goldmuntz E, Krantz ID. Congenital heart disease in Cornelia de Lange syndrome: phenotype and genotype analysis. Am J Med Genet A. 2012. 10.1002/ajmg.a.35582.</mixed-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<mixed-citation publication-type="other">Jackson L, Kline AD, Barr MA, Koch S. de Lange syndrome: a clinical review of 310 individuals. Am J Med Genet. 1993. 10.1002/ajmg.1320470703.</mixed-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<mixed-citation publication-type="other">Tsukahara M, Okamoto N, Ohashi H, Kuwajima K, Kondo I, Sugie H, Nagai T, Naritomi K, Hasegawa T, Fukushima Y, Masuno M, Kuroki Y. Brachman-de Lange syndrome and congenital heart disease. Am J Med Genet A. 1998. 10.1002/(SICI)1096-8628(19980203)75:4&lt;441::AID-AJMG20&gt;3.0.CO;2-N.</mixed-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<mixed-citation publication-type="other">Barisic I, Tokic V, Loane M, Bianchi F, Calzolari E, Garne E, Wellesley D, Dolk H. Descriptive epidemiology of Cornelia de Lange syndrome in Europe. Am J Med Genet A. 2007. 10.1002/ajmg.a.32016.</mixed-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<mixed-citation publication-type="other">Bhuiyan ZA, Stewart H, Redeker EJ, Mannens MMAM, Hennekam RCM. Large demonic rearrangements in NIPBL are infrequent in Cornelia de Lange syndrome. Eur J Hum Genet. 2007. 10.1038/sj.ejhg.5201776.</mixed-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnston</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Farra</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Double lumen aortic arch in association with tetralogy of Fallot</article-title>
<source/>Images of Paediatric Cardiol
          <year>2006</year>
<volume>6</volume>
<fpage>5</fpage>
<lpage>7</lpage>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<mixed-citation publication-type="other">Selicorni A, Colli AM, Passarini A, Milani D, Cereda A, Cerutti M, Maitz S, Alloni V, Salvini L, Galli MA, Ghiglia S, Salice P, Danzi GB. Analysis of congenital heart defects in 87 consecutive patients with Brachmann-de Lange syndrome. Am J Med Genet A. 2009. 10.1002/ajmg.a.32838.</mixed-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<mixed-citation publication-type="other">Reith W, Haussmann A. Dandy-Walker-malformation. Radiologe. 2018. 10.1007/s00117-018-0403-7.</mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>